(+)-dexrazoxane multiple interactions ISO RGD:1316728 6480464 [Dexrazoxane co-treated with Idarubicin] results in increased expression of RAD51 mRNA CTD PMID:28973540 (-)-demecolcine affects localization EXP 6480464 Demecolcine affects the localization of RAD51 protein CTD PMID:9885240 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1316727 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RAD51 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:1316728 6480464 vinylidene chloride results in increased expression of RAD51 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1316728 6480464 ethylene dichloride results in decreased expression of RAD51 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RAD51 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1316727 6480464 Estradiol results in increased expression of RAD51 mRNA CTD PMID:16474171 , PMID:18310284 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1316728 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:20566336 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1316728 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316727 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of RAD51 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RAD51 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RAD51 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316728 6480464 Tetrachlorodibenzodioxin affects the expression of RAD51 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316728 6480464 Tetrachlorodibenzodioxin results in increased expression of RAD51 mRNA CTD PMID:15667827 2,4-diaminotoluene increases expression ISO RGD:1316728 6480464 2, 4-diaminotoluene results in increased expression of RAD51 mRNA CTD PMID:20713471 3-methylcholanthrene increases expression ISO RGD:1316728 6480464 Methylcholanthrene results in increased expression of RAD51 mRNA CTD PMID:20713471 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid decreases activity ISO RGD:1316727 6480464 4 more ... CTD PMID:23589568 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO RGD:1316727 6480464 [4 more ... CTD PMID:23589568 4-hydroperoxycyclophosphamide decreases expression EXP 6480464 perfosfamide results in decreased expression of RAD51 mRNA CTD PMID:11754170 4-hydroxynon-2-enal decreases expression ISO RGD:1316728 6480464 4-hydroxy-2-nonenal results in decreased expression of RAD51 mRNA CTD PMID:19191707 4-hydroxynon-2-enal increases expression ISO RGD:1316728 6480464 4-hydroxy-2-nonenal results in increased expression of RAD51 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1316728 6480464 Fenretinide results in increased expression of RAD51 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects localization ISO RGD:1316727 6480464 Decitabine affects the localization of RAD51 protein modified form CTD PMID:17991895 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of RAD51 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:23969067 7,12-dimethyltetraphene multiple interactions ISO RGD:1316728 6480464 A gene mutant form affects the reaction [9 more ... CTD PMID:25448685 7,12-dimethyltetraphene increases expression ISO RGD:1316728 6480464 9 more ... CTD PMID:25448685 , PMID:32553695 7,9-dihydro-1H-purine-2,6,8(3H)-trione decreases expression ISO RGD:1316728 6480464 Uric Acid results in decreased expression of RAD51 mRNA CTD PMID:23619996 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:1316728 6480464 NLRP3 gene mutant form inhibits the reaction [Uric Acid results in decreased expression of RAD51 mRNA] CTD PMID:23619996 acetamide increases expression EXP 6480464 acetamide results in increased expression of RAD51 mRNA CTD PMID:31881176 acetylleucyl-leucyl-norleucinal multiple interactions ISO RGD:1316727 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [[Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA], acetylleucyl-leucyl-norleucinal inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased expression of RAD51 protein]] CTD PMID:21810436 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of RAD51 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1316727 6480464 Acrylamide results in decreased expression of RAD51 mRNA CTD PMID:32763439 actinomycin D multiple interactions ISO RGD:1316727 6480464 tetrachlorobenzoquinone promotes the reaction [Dactinomycin results in decreased expression of RAD51 mRNA] CTD PMID:27989139 actinomycin D decreases expression ISO RGD:1316727 6480464 Dactinomycin results in decreased expression of RAD51 mRNA CTD PMID:27989139 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of RAD51 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 increases expression ISO RGD:1316727 6480464 Aflatoxin B1 results in increased expression of RAD51 mRNA CTD PMID:29445054 all-trans-retinoic acid affects expression ISO RGD:1316727 6480464 Tretinoin affects the expression of RAD51 mRNA CTD PMID:31600526 amsacrine affects response to substance ISO RGD:1316727 6480464 RAD51 protein affects the susceptibility to Amsacrine CTD PMID:16600179 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1316727 6480464 pyrazolanthrone inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA] CTD PMID:22579953 arsane affects methylation ISO RGD:1316727 6480464 Arsenic affects the methylation of RAD51 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1316727 6480464 Arsenic affects the methylation of RAD51 gene CTD PMID:25304211 arsenite(3-) decreases expression ISO RGD:1316728 6480464 arsenite results in decreased expression of RAD51 mRNA CTD PMID:18929588 benzene decreases expression ISO RGD:1316727 6480464 Benzene results in decreased expression of RAD51 mRNA CTD PMID:18724895 benzene multiple interactions ISO RGD:1316728 6480464 TRP53 protein affects the reaction [Benzene results in decreased expression of RAD51 mRNA] CTD PMID:12928149 benzene increases expression ISO RGD:1316728 6480464 Benzene results in increased expression of RAD51 mRNA CTD PMID:15342939 benzo[a]pyrene decreases expression ISO RGD:1316727 6480464 Benzo(a)pyrene results in decreased expression of RAD51 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:1316727 6480464 Benzo(a)pyrene results in increased expression of RAD51 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1316727 6480464 Benzo(a)pyrene affects the methylation of RAD51 intron CTD PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1316728 6480464 Benzo(a)pyrene results in increased expression of RAD51 mRNA CTD PMID:20713471 , PMID:32417428 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1316727 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1316728 6480464 benzo(b)fluoranthene results in increased expression of RAD51 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 benzo[e]pyrene decreases methylation ISO RGD:1316727 6480464 benzo(e)pyrene results in decreased methylation of RAD51 intron CTD PMID:30157460 biphenyl-4-amine decreases expression ISO RGD:1316727 6480464 4-biphenylamine results in decreased expression of RAD51 mRNA, 4-biphenylamine results in decreased expression of RAD51 protein CTD PMID:24857880 more ... biphenyl-4-amine multiple interactions ISO RGD:1316727 6480464 Propolis inhibits the reaction [4-biphenylamine results in decreased expression of RAD51 protein], TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of RAD51 mRNA] CTD PMID:32905825 , PMID:33847444 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1316727 6480464 BRCA2 protein inhibits the reaction [Mustard Gas affects the localization of RAD51 protein] CTD PMID:20435105 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1316727 6480464 Mustard Gas results in decreased expression of RAD51 mRNA CTD PMID:33491125 bis(2-chloroethyl) sulfide decreases response to substance ISO RGD:1316727 6480464 RAD51 protein results in decreased susceptibility to Mustard Gas CTD PMID:20435105 bis(2-chloroethyl) sulfide affects localization ISO RGD:1316727 6480464 Mustard Gas affects the localization of RAD51 protein CTD PMID:20435105 bisphenol A increases expression ISO RGD:1316727 6480464 bisphenol A results in increased expression of RAD51 mRNA CTD PMID:16474171 , PMID:22576693 bisphenol A decreases expression ISO RGD:1316727 6480464 bisphenol A results in decreased expression of RAD51 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RAD51 mRNA CTD PMID:25181051 bortezomib decreases expression ISO RGD:1316727 6480464 Bortezomib results in decreased expression of RAD51 mRNA CTD PMID:21917757 bromoacetate increases expression ISO RGD:1316727 6480464 bromoacetate results in increased expression of RAD51 mRNA CTD PMID:19753638 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of RAD51 mRNA CTD PMID:32479839 busulfan decreases expression ISO RGD:1316728 6480464 Busulfan results in decreased expression of RAD51 mRNA CTD PMID:15388331 cadmium dichloride increases expression ISO RGD:1316727 6480464 Cadmium Chloride results in increased expression of RAD51 mRNA CTD PMID:12160620 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of RAD51 mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:1316727 6480464 Calcitriol results in decreased expression of RAD51 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1316727 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RAD51 mRNA CTD PMID:21592394 camptothecin decreases expression ISO RGD:1316727 6480464 Camptothecin results in decreased expression of RAD51 mRNA, Camptothecin results in decreased expression of RAD51 protein CTD PMID:10344722 , PMID:24792648 carbamazepine affects expression ISO RGD:1316727 6480464 Carbamazepine affects the expression of RAD51 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:1316728 6480464 Nanotubes more ... CTD PMID:25554681 carmustine decreases expression ISO RGD:1316727 6480464 Carmustine results in decreased expression of RAD51 mRNA CTD PMID:15980968 chlorambucil increases expression ISO RGD:1316727 6480464 Chlorambucil results in increased expression of RAD51 protein CTD PMID:10473103 chlordecone increases expression ISO RGD:1316728 6480464 Chlordecone results in increased expression of RAD51 mRNA CTD PMID:31084621 chlorothalonil increases expression ISO RGD:1316728 6480464 tetrachloroisophthalonitrile results in increased expression of RAD51 protein CTD PMID:30586609 choline multiple interactions ISO RGD:1316728 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAD51 more ... CTD PMID:20938992 chromium(6+) multiple interactions ISO RGD:1316727 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of RAD51 mRNA more ... CTD PMID:25173789 more ... chromium(6+) decreases expression ISO RGD:1316727 6480464 chromium hexavalent ion results in decreased expression of RAD51 mRNA CTD PMID:30690063 chrysene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of RAD51 mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1316728 6480464 Cisplatin results in increased expression of RAD51 protein CTD PMID:26723870 cisplatin multiple interactions ISO RGD:1316728 6480464 NQO1 protein affects the reaction [Cisplatin results in increased expression of RAD51 protein] CTD PMID:26723870 cisplatin increases expression ISO RGD:1316727 6480464 Cisplatin results in increased expression of RAD51 mRNA, Cisplatin results in increased expression of RAD51 protein CTD PMID:26723870 , PMID:27594783 copper atom multiple interactions ISO RGD:1316727 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RAD51 mRNA CTD PMID:20971185 copper atom increases expression ISO RGD:1316728 6480464 Copper results in increased expression of RAD51 mRNA CTD PMID:17205981 copper(0) multiple interactions ISO RGD:1316727 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RAD51 mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:1316728 6480464 Copper results in increased expression of RAD51 mRNA CTD PMID:17205981 copper(II) sulfate decreases expression ISO RGD:1316727 6480464 Copper Sulfate results in decreased expression of RAD51 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1316727 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1316727 6480464 Coumestrol results in increased expression of RAD51 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1316728 6480464 Asbestos, Crocidolite results in increased expression of RAD51 mRNA CTD PMID:29279043 crocidolite asbestos decreases expression ISO RGD:1316727 6480464 Asbestos, Crocidolite results in decreased expression of RAD51 mRNA CTD PMID:29523930 CU-O LINKAGE increases expression ISO RGD:1316727 6480464 cupric oxide results in increased expression of RAD51 mRNA CTD PMID:32285662 curcumin multiple interactions ISO RGD:1316727 6480464 [Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA more ... CTD PMID:21810436 cyclophosphamide decreases expression ISO RGD:1316728 6480464 Cyclophosphamide results in decreased expression of RAD51 mRNA CTD PMID:21041162 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of RAD51 mRNA CTD PMID:11599041 cyclosporin A decreases expression ISO RGD:1316727 6480464 Cyclosporine results in decreased expression of RAD51 mRNA CTD PMID:25562108 cylindrospermopsin decreases expression ISO RGD:1316727 6480464 cylindrospermopsin results in decreased expression of RAD51 mRNA CTD PMID:23726867 cypermethrin increases expression ISO RGD:1316728 6480464 cypermethrin results in increased expression of RAD51 mRNA CTD PMID:21142847 cytarabine increases expression ISO RGD:1316727 6480464 Cytarabine results in increased expression of RAD51 mRNA CTD PMID:19194470 decabromodiphenyl ether decreases expression ISO RGD:1316728 6480464 decabromobiphenyl ether results in decreased expression of RAD51 mRNA, decabromobiphenyl ether results in decreased expression of RAD51 protein CTD PMID:34936917 dexamethasone decreases expression ISO RGD:1316728 6480464 Dexamethasone results in decreased expression of RAD51 mRNA CTD PMID:21041162 dibenz[a,h]anthracene increases expression ISO RGD:1316728 6480464 1 more ... CTD PMID:26377693 dibenzofuran decreases expression EXP 6480464 dibenzofuran analog results in decreased expression of RAD51 mRNA CTD PMID:20566336 dichloroacetic acid increases expression ISO RGD:1316728 6480464 Dichloroacetic Acid results in increased expression of RAD51 mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:1316727 6480464 Diclofenac affects the expression of RAD51 mRNA CTD PMID:24752500 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of RAD51 mRNA CTD PMID:30723492 diethylstilbestrol decreases expression ISO RGD:1316728 6480464 Diethylstilbestrol results in decreased expression of RAD51 mRNA CTD PMID:21041162 dioxygen decreases expression ISO RGD:1316727 6480464 Oxygen deficiency results in decreased expression of RAD51 mRNA, Oxygen deficiency results in decreased expression of RAD51 protein CTD PMID:25030372 more ... disodium selenite decreases expression ISO RGD:1316727 6480464 Sodium Selenite results in decreased expression of RAD51 mRNA, Sodium Selenite results in decreased expression of RAD51 protein CTD PMID:10344722 , PMID:18175754 doxorubicin affects expression ISO RGD:1316727 6480464 Doxorubicin affects the expression of RAD51 protein CTD PMID:17351394 doxorubicin increases expression ISO RGD:1316727 6480464 Doxorubicin results in increased expression of RAD51 mRNA CTD PMID:34783124 doxorubicin multiple interactions ISO RGD:1316727 6480464 ginsenoside Rg1 promotes the reaction [Doxorubicin results in increased expression of RAD51 mRNA] CTD PMID:34783124 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of RAD51 mRNA, Doxorubicin results in decreased expression of RAD51 protein CTD PMID:24902966 , PMID:27181935 doxorubicin multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Doxorubicin results in decreased expression of RAD51 mRNA], Quercetin inhibits the reaction [Doxorubicin results in decreased expression of RAD51 protein] CTD PMID:24902966 , PMID:27181935 doxorubicin decreases expression ISO RGD:1316727 6480464 Doxorubicin results in decreased expression of RAD51 mRNA, Doxorubicin results in decreased expression of RAD51 protein CTD PMID:10344722 endosulfan multiple interactions ISO RGD:1316727 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of RAD51 mRNA CTD PMID:26159488 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of RAD51 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1316727 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1316727 6480464 entinostat results in increased expression of RAD51 protein CTD PMID:34665271 epoxiconazole increases expression ISO RGD:1316728 6480464 epoxiconazole results in increased expression of RAD51 mRNA CTD PMID:35436446 erlotinib hydrochloride multiple interactions ISO RGD:1316727 6480464 [Erlotinib Hydrochloride results in decreased activity of EGFR protein] which results in decreased expression of RAD51 protein CTD PMID:23548265 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of RAD51 mRNA CTD PMID:24412560 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of RAD51 mRNA CTD PMID:24412560 Estragole increases expression EXP 6480464 estragole results in increased expression of RAD51 protein CTD PMID:29054680 etoposide affects localization EXP 6480464 Etoposide affects the localization of RAD51 protein CTD PMID:9885240 fenthion decreases expression ISO RGD:1316727 6480464 Fenthion results in decreased expression of RAD51 mRNA, Fenthion results in decreased expression of RAD51 protein CTD PMID:33221015 fenthion multiple interactions ISO RGD:1316727 6480464 Fenthion inhibits the reaction [terbufos results in decreased expression of RAD51 protein], terbufos inhibits the reaction [Fenthion results in decreased expression of RAD51 protein] CTD PMID:33221015 flumequine multiple interactions ISO RGD:1316728 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 folic acid multiple interactions ISO RGD:1316728 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAD51 more ... CTD PMID:20938992 folic acid decreases expression ISO RGD:1316728 6480464 Folic Acid results in decreased expression of RAD51 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1316727 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of RAD51 mRNA CTD PMID:19016759 fulvestrant decreases expression ISO RGD:1316727 6480464 fulvestrant results in decreased expression of RAD51 mRNA CTD PMID:19016759 furan decreases expression EXP 6480464 furan results in decreased expression of RAD51 mRNA CTD PMID:22507866 furan increases expression EXP 6480464 furan results in increased expression of RAD51 mRNA CTD PMID:25539665 gallic acid increases expression ISO RGD:1316727 6480464 Gallic Acid results in increased expression of RAD51 mRNA CTD PMID:34408198 gefitinib affects response to substance ISO RGD:1316727 6480464 RAD51 protein affects the susceptibility to Gefitinib CTD PMID:34998818 genistein increases expression ISO RGD:1316727 6480464 Genistein results in increased expression of RAD51 mRNA CTD PMID:16474171 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of RAD51 mRNA CTD PMID:33387578 geraniol decreases expression ISO RGD:1316727 6480464 geraniol results in decreased expression of RAD51 mRNA CTD PMID:27683099 ginsenoside Rg1 multiple interactions ISO RGD:1316727 6480464 ginsenoside Rg1 promotes the reaction [Doxorubicin results in increased expression of RAD51 mRNA] CTD PMID:34783124 hydrogen peroxide decreases expression ISO RGD:1316727 6480464 Hydrogen Peroxide results in decreased expression of RAD51 protein CTD PMID:33847444 hydrogen peroxide multiple interactions ISO RGD:1316727 6480464 Propolis inhibits the reaction [Hydrogen Peroxide results in decreased expression of RAD51 protein] CTD PMID:33847444 idarubicin multiple interactions ISO RGD:1316728 6480464 [Dexrazoxane co-treated with Idarubicin] results in increased expression of RAD51 mRNA CTD PMID:28973540 irinotecan multiple interactions ISO RGD:1316727 6480464 [Irinotecan co-treated with 2-(morpholin-4-yl)benzo(h)chromen-4-one] results in increased expression of RAD51 protein, [Irinotecan co-treated with IC486241] results in increased expression of RAD51 protein CTD PMID:21221710 irinotecan increases expression ISO RGD:1316727 6480464 Irinotecan results in increased expression of RAD51 protein CTD PMID:21221710 L-methionine multiple interactions ISO RGD:1316728 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of RAD51 more ... CTD PMID:20938992 leflunomide decreases expression ISO RGD:1316727 6480464 leflunomide results in decreased expression of RAD51 mRNA CTD PMID:28988120 , PMID:29427785 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of RAD51 mRNA CTD PMID:35283115 lipopolysaccharide increases expression ISO RGD:1316728 6480464 Lipopolysaccharides results in increased expression of RAD51 mRNA CTD PMID:12057914 lucanthone decreases expression ISO RGD:1316727 6480464 Lucanthone results in decreased expression of RAD51 mRNA CTD PMID:21148553 mechlorethamine increases expression ISO RGD:1316728 6480464 Mechlorethamine results in increased expression of RAD51 protein CTD PMID:25891025 MeIQx multiple interactions ISO RGD:1316728 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 menadione affects expression ISO RGD:1316727 6480464 Vitamin K 3 affects the expression of RAD51 mRNA CTD PMID:20044591 methapyrilene decreases methylation ISO RGD:1316727 6480464 Methapyrilene results in decreased methylation of RAD51 intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1316727 6480464 Methyl Methanesulfonate results in increased expression of RAD51 mRNA CTD PMID:23649840 mitomycin C multiple interactions ISO RGD:1316727 6480464 [Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA more ... CTD PMID:21810436 mitomycin C increases expression ISO RGD:1316727 6480464 Mitomycin results in increased expression of RAD51 protein CTD PMID:21810436 myristicin decreases expression ISO RGD:1316727 6480464 myristicin results in decreased expression of RAD51 mRNA CTD PMID:24792648 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1316727 6480464 N more ... CTD PMID:12888634 N,N-dimethylformamide increases expression ISO RGD:1316727 6480464 Dimethylformamide results in increased expression of RAD51 mRNA, Dimethylformamide results in increased expression of RAD51 protein CTD PMID:26387567 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1316727 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Mitomycin co-treated with Curcumin] results in decreased expression of RAD51 mRNA], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin inhibits the reaction [Mitomycin results in increased expression of RAD51 protein]] CTD PMID:21810436 N-nitrosodiethylamine multiple interactions ISO RGD:1316728 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RAD51 mRNA, RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RAD51 mRNA] CTD PMID:17854601 , PMID:24535843 N-nitrosodiethylamine increases expression ISO RGD:1316728 6480464 Diethylnitrosamine results in increased expression of RAD51 mRNA, Diethylnitrosamine results in increased expression of RAD51 protein CTD PMID:17854601 , PMID:18506893 nickel atom increases expression ISO RGD:1316727 6480464 Nickel results in increased expression of RAD51 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of RAD51 mRNA CTD PMID:22110744 nickel dichloride decreases expression ISO RGD:1316727 6480464 nickel chloride results in decreased expression of RAD51 mRNA, nickel chloride results in decreased expression of RAD51 protein CTD PMID:28472268 Nonidet P-40 decreases expression ISO RGD:1316727 6480464 Nonidet P-40 results in decreased expression of RAD51 mRNA CTD PMID:26552463 ochratoxin A multiple interactions ISO RGD:1316727 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ochratoxin A results in decreased expression of RAD51] more ... CTD PMID:24525463 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of RAD51 mRNA, ochratoxin A results in increased expression of RAD51 protein CTD PMID:24243707 ochratoxin A decreases expression ISO RGD:1316727 6480464 ochratoxin A results in decreased expression of RAD51 CTD PMID:24525463 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RAD51 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of RAD51 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1316728 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RAD51 mRNA more ... CTD PMID:19555225 more ... paracetamol increases expression ISO RGD:1316727 6480464 Acetaminophen results in increased expression of RAD51 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RAD51 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:1316728 6480464 [2 more ... CTD PMID:25510870 phenethyl isothiocyanate decreases expression ISO RGD:1316727 6480464 phenethyl isothiocyanate results in decreased expression of RAD51 mRNA CTD PMID:26678675 phenobarbital multiple interactions ISO RGD:1316728 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RAD51 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RAD51 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1316728 6480464 Phenobarbital results in increased expression of RAD51 mRNA CTD PMID:19482888 more ... phosphoramide mustard affects expression EXP 6480464 phosphoramide mustard affects the expression of RAD51 mRNA, phosphoramide mustard affects the expression of RAD51 protein CTD PMID:25497287 phosphoramide mustard decreases expression EXP 6480464 phosphoramide mustard results in decreased expression of RAD51 protein CTD PMID:26708502 phosphoramide mustard increases expression EXP 6480464 phosphoramide mustard results in increased expression of RAD51 mRNA CTD PMID:26708502 phytoestrogen increases expression ISO RGD:1316727 6480464 Phytoestrogens results in increased expression of RAD51 mRNA CTD PMID:18310284 pirinixic acid multiple interactions ISO RGD:1316728 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of RAD51 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of RAD51 mRNA] CTD PMID:17950772 , PMID:20813756 pirinixic acid increases expression ISO RGD:1316728 6480464 pirinixic acid results in increased expression of RAD51 mRNA CTD PMID:17950772 more ... potassium chromate multiple interactions ISO RGD:1316727 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RAD51 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1316727 6480464 potassium chromate(VI) results in decreased expression of RAD51 mRNA CTD PMID:22079256 , PMID:22714537 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1316728 6480464 [1 more ... CTD PMID:23626729 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1316728 6480464 Pregnenolone Carbonitrile results in increased expression of RAD51 mRNA CTD PMID:22698814 prodigiosin multiple interactions ISO RGD:1316727 6480464 pyrazolanthrone inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA], SB 203580 inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA] CTD PMID:22579953 prodigiosin decreases response to substance ISO RGD:1316727 6480464 RAD51 protein results in decreased susceptibility to Prodigiosin CTD PMID:22579953 prodigiosin decreases expression ISO RGD:1316727 6480464 Prodigiosin results in decreased expression of RAD51 mRNA, Prodigiosin results in decreased expression of RAD51 protein CTD PMID:22579953 progesterone affects expression ISO RGD:1316728 6480464 Progesterone affects the expression of RAD51 mRNA CTD PMID:17251523 propiconazole increases expression ISO RGD:1316728 6480464 propiconazole results in increased expression of RAD51 mRNA CTD PMID:21278054 quercetin increases expression EXP 6480464 Quercetin results in increased expression of RAD51 protein CTD PMID:24902966 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Doxorubicin results in decreased expression of RAD51 protein] CTD PMID:24902966 quizartinib decreases expression ISO RGD:1316727 6480464 quizartinib results in decreased expression of RAD51 protein CTD PMID:34665271 quizartinib multiple interactions ISO RGD:1316727 6480464 quizartinib promotes the reaction [romidepsin results in decreased expression of RAD51 protein], romidepsin promotes the reaction [quizartinib results in decreased expression of RAD51 protein] CTD PMID:34665271 resveratrol increases expression ISO RGD:1316727 6480464 resveratrol results in increased expression of RAD51 mRNA CTD PMID:15149879 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of RAD51 mRNA CTD PMID:33775663 resveratrol multiple interactions ISO RGD:1316727 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of RAD51 mRNA more ... CTD PMID:19167446 , PMID:23557933 romidepsin multiple interactions ISO RGD:1316727 6480464 quizartinib promotes the reaction [romidepsin results in decreased expression of RAD51 protein], romidepsin promotes the reaction [quizartinib results in decreased expression of RAD51 protein] CTD PMID:34665271 romidepsin decreases expression ISO RGD:1316727 6480464 romidepsin results in decreased expression of RAD51 protein CTD PMID:34665271 rotenone increases expression ISO RGD:1316727 6480464 Rotenone results in increased expression of RAD51 mRNA CTD PMID:18191903 SB 203580 multiple interactions ISO RGD:1316727 6480464 SB 203580 inhibits the reaction [ochratoxin A results in decreased expression of RAD51], SB 203580 inhibits the reaction [Prodigiosin results in decreased expression of RAD51 mRNA] CTD PMID:22579953 , PMID:24525463 silicon dioxide increases expression ISO RGD:1316728 6480464 Silicon Dioxide results in increased expression of RAD51 mRNA CTD PMID:29341224 sirolimus multiple interactions ISO RGD:1316727 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of RAD51 mRNA CTD PMID:19016759 sodium arsenite decreases expression ISO RGD:1316728 6480464 sodium arsenite results in decreased expression of RAD51 mRNA CTD PMID:16014739 , PMID:25787150 sodium arsenite increases expression ISO RGD:1316727 6480464 sodium arsenite results in increased expression of RAD51 mRNA CTD PMID:29301061 , PMID:34032870 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of RAD51 mRNA CTD PMID:22110744 sodium dichromate decreases expression ISO RGD:1316728 6480464 sodium bichromate results in decreased expression of RAD51 mRNA CTD PMID:31558096 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RAD51 mRNA CTD PMID:25993096 sodium dichromate increases expression ISO RGD:1316728 6480464 sodium bichromate results in increased expression of RAD51 mRNA CTD PMID:22155349 sunitinib decreases expression ISO RGD:1316727 6480464 Sunitinib results in decreased expression of RAD51 mRNA CTD PMID:31533062 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of RAD51 protein CTD PMID:17219426 terbufos multiple interactions ISO RGD:1316727 6480464 Fenthion inhibits the reaction [terbufos results in decreased expression of RAD51 protein], terbufos inhibits the reaction [Fenthion results in decreased expression of RAD51 protein] CTD PMID:33221015 terbufos decreases expression ISO RGD:1316727 6480464 terbufos results in decreased expression of RAD51 mRNA, terbufos results in decreased expression of RAD51 protein CTD PMID:33221015 testosterone multiple interactions ISO RGD:1316727 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RAD51 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1316727 6480464 Testosterone results in increased expression of RAD51 mRNA CTD PMID:33359661 testosterone decreases expression ISO RGD:1316727 6480464 Testosterone results in decreased expression of RAD51 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1316728 6480464 Carbon Tetrachloride results in increased expression of RAD51 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane affects expression ISO RGD:1316728 6480464 Carbon Tetrachloride affects the expression of RAD51 mRNA CTD PMID:17484886 tetraphene multiple interactions ISO RGD:1316728 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RAD51 mRNA CTD PMID:22659510 , PMID:34492290 titanium dioxide increases expression ISO RGD:1316728 6480464 titanium dioxide results in increased expression of RAD51 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of RAD51 mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RAD51 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1316728 6480464 Trichloroethylene results in increased expression of RAD51 mRNA CTD PMID:25549359 trichostatin A decreases expression ISO RGD:1316727 6480464 trichostatin A results in decreased expression of RAD51 mRNA CTD PMID:23770000 trimellitic anhydride increases expression ISO RGD:1316728 6480464 trimellitic anhydride results in increased expression of RAD51 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1316727 6480464 troglitazone results in decreased expression of RAD51 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:1316728 6480464 trovafloxacin results in decreased expression of RAD51 mRNA CTD PMID:35537566 urethane decreases expression ISO RGD:1316727 6480464 Urethane results in decreased expression of RAD51 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1316727 6480464 Valproic Acid results in decreased expression of RAD51 mRNA CTD PMID:20585447 valproic acid decreases expression ISO RGD:1316728 6480464 Valproic Acid results in decreased expression of RAD51 mRNA CTD PMID:24913804 valproic acid increases expression ISO RGD:1316728 6480464 Valproic Acid results in increased expression of RAD51 mRNA CTD PMID:24913804 vorinostat decreases expression ISO RGD:1316727 6480464 vorinostat results in decreased expression of RAD51 protein CTD PMID:20646843 zearalenone increases expression ISO RGD:1316728 6480464 Zearalenone results in increased expression of RAD51 mRNA, Zearalenone results in increased expression of RAD51 protein CTD PMID:28552778 , PMID:35650142 zearalenone decreases expression ISO RGD:1316728 6480464 Zearalenone results in decreased expression of RAD51 mRNA CTD PMID:27862621 zinc oxide multiple interactions ISO RGD:1316728 6480464 Zinc Oxide affects the splicing of and results in increased expression of RAD51 mRNA CTD PMID:30500950